Sancho J, Chatila T, Wong R C, Hall C, Blumberg R, Alarcon B, Geha R S, Terhorst C
Laboratory of Molecular Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
J Biol Chem. 1989 Dec 5;264(34):20760-9.
In order to study the relationship between assembly, surface expression, and signal transduction of the alpha/beta T-cell antigen receptor-CD3 complex (TCR.CD3), a series of T-cell mutants with a partial block in assembly of the complex was generated. By chemical mutagenesis, we produced somatic cell variants of the human T-leukemia cell line, HPB-ALL, which expressed low amounts of TCR.CD3 complexes on their surface. RNA and protein analyses demonstrated that most variants synthesized normal amounts of the individual members of the complex, i.e. TCR-alpha, TCR-beta, CD3-gamma, -delta, -epsilon, and -zeta. In these variants, less than 10% of the TCR.CD3 complexes inside the cell contained the CD3-zeta 2 homodimer due to an intrinsic deficiency in the formation of the TCR-alpha/beta heterodimer. The low level of assembly of CD3-zeta 2 into the TCR.CD3 complex and an additional decrease in the rate of export of the TCR.CD3 complex from the endoplasmic reticulum explained the low level of expression of alpha/beta receptors on the surface of these mutants. Only cells with the complete set of subunits of the TCR.CD3 complex on their surface were capable of transducing CD3-mediated signals. The results presented in this paper indicate that TCR-alpha/beta heterodimer formation is an obligatory requirement for assemblage of CD3-zeta 2 into a functionally competent TCR.CD3 complex.
为了研究α/β T细胞抗原受体-CD3复合物(TCR.CD3)的组装、表面表达和信号转导之间的关系,我们构建了一系列在复合物组装过程中存在部分阻断的T细胞突变体。通过化学诱变,我们获得了人T白血病细胞系HPB-ALL的体细胞变体,这些变体在其表面表达少量的TCR.CD3复合物。RNA和蛋白质分析表明,大多数变体合成的复合物单个成员(即TCR-α、TCR-β、CD3-γ、-δ、-ε和-ζ)数量正常。在这些变体中,由于TCR-α/β异二聚体形成存在内在缺陷,细胞内少于10%的TCR.CD3复合物包含CD3-ζ2同二聚体。CD3-ζ2组装到TCR.CD3复合物中的水平较低,以及TCR.CD3复合物从内质网输出速率的进一步降低,解释了这些突变体表面α/β受体表达水平较低的原因。只有表面具有完整TCR.CD3复合物体亚基的细胞才能转导CD3介导的信号。本文给出的结果表明,TCR-α/β异二聚体的形成是将CD3-ζ2组装成功能上有活性的TCR.CD3复合物的必要条件。